ArticleClinical cancer research : an official journal of the American Association for Cancer Research2013

c-Src activation mediates erlotinib resistance in head and neck cancer by stimulating c-Met.

Laura P Stabile et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.